#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chemical burn Juvenile chronic myelomonocytic leukaemia Adrenoleukodystrophy Follicular lymphoma Type IIa hyperlipidaemia Heart disease congenital Antiphospholipid syndrome Angiosarcoma Selective polysaccharide antibody deficiency Krabbe's disease Lymphangioma Synovial sarcoma B-cell lymphoma recurrent Ureteric cancer Chronic myeloid leukaemia (in remission) More trials…

    Learn about Rare Diseases

    Mitochondrial myopathy – Treatment Wiskott-Aldrich syndrome – Diagnostics Leiomyosarcoma metastatic – Life with Disease Tuberous sclerosis complex – Treatment Richter’s syndrome – Diagnostics Wiskott-Aldrich syndrome – Trials in Disease Netherton’s syndrome – Trials in Disease Alagille syndrome Turner’s syndrome – Life with Disease Myelodysplastic syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    PEGZILARGINASE Emtricitabine Ads-015 Diroximel Fumarate Quercus Ilex Allergen Extract Rifapentine Ltp001 Gskvx000000008885 Nefopam Imifoplatin Carbamazepine (Ph. Eur.) Azd5004 Bupropion Hydrochloride Bi 765845 ALXN1920 Ixazomib Citrate TUB-030 Budigalimab Ropeginterferon Alfa-2B Tecovirimat More therapies…

    Learn about Your Condition

    Melanoma recurrent Bone sarcoma Hereditary ataxia Colonoscopy Pericarditis Myositis Hepatobiliary disease Colorectal cancer metastatic Bone marrow disorder Hypertension Rasmussen encephalitis Tertiary adrenal insufficiency Biopsy heart Arrhythmia supraventricular Schizoaffective disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of Cemiplimab Combined with Imiquimod and Laser Therapy Before Surgery for High-Risk Skin Basal Cell Carcinoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Basal cell carcinoma
    Investigated Drugs:
    • Imiquimod
    • Cemiplimab
    Spain

  • Preoperative Elacestrant and PULSAR Adaptive Radiotherapy for Hormone Receptor-Positive, HER2-Negative Breast Cancer: A Study for Patients with Stage II-III Disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    Italy

  • Effectiveness of Macrogol 3350 With Electrolytes and Sodium Picosulfate/Magnesium Citrate Combination for Bowel Preparation in Patients With Inadequate Previous Colonoscopy Preparation

    Recruiting

    3 1 1
    Investigated Drugs:
    • Macrogol 3350
    • Sodium Hydrogen Carbonate
    • Sodium Chloride
    Greece

  • Study to Evaluate IOpener-Melanoma Test for Predicting Response to Immunotherapy in Stage III or IV Skin Melanoma Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    Investigated Drugs:
    • Nivolumab
    • Pembrolizumab
    The Netherlands

  • Study on the Effects and Safety of Rilzabrutinib for Adults with Graves’ Disease

    Recruiting

    2 1 1
    Investigated Drugs:
    • Rilzabrutinib
    Germany Greece Hungary Italy Spain

  • Study of Darolutamide and Testosterone for Patients with Advanced Prostate Cancer Resistant to Standard Hormone Therapy

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Testosterone
    • Enzalutamide
    • Abiraterone
    Germany
Previous Page
1 … 167 168 169 170 171 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!